Assignee
ONTOGENESIS LLC
US·3 granted patents·6 pending applications·1 citations·filing 2016–2020
Top patents by PatentIndex Score
9 records- 0175US10464902B1Multi-tyrosine kinase inhibitors derivatives and methods of useONTOGENESIS LLC·Filed 2017·Granted Nov 5, 2019·1 cites·2 claims
- 0273US10899712B2Multi-tyrosine kinase inhibitors derivatives and methods of useONTOGENESIS LLC·Filed 2019·Granted Jan 26, 2021·0 cites·2 claims
- 0367US11623917B2Multi-tyrosine kinase inhibitors derivatives and methods of useONTOGENESIS LLC·Filed 2020·Granted Apr 11, 2023·0 cites·10 claims
- 0445US2018009758A1Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of UseONTOGENESIS LLC·Filed 2017·Application pending·0 cites
- 0544US2017342033A1Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of UseONTOGENESIS LLC·Filed 2017·Application pending·0 cites
- 0643US2017143688A1Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of UseONTOGENESIS LLC·Filed 2017·Application pending·0 cites
- 0743US2017112821A1Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of UseONTOGENESIS LLC·Filed 2017·Application pending·0 cites
- 0836US2017020856A1N-Acylalkyl Prodrugs of Multi-Tyrosine Kinase Inhibitors and Methods of UseONTOGENESIS LLC·Filed 2016·Application pending·0 cites
- 0935US2016376239A1N-Acylalkyl Prodrugs of Multi-Tyrosine Kinase Inhibitors and Methods of UseONTOGENESIS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONTOGENESIS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →